MedTrace Logo

Weight Loss Pilot Study in Postmenopausal Breast Cancer Survivors

NCT02940470 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 22

Last updated 2018-08-03

No results posted yet for this study

Summary

The primary objective of this pilot study is to determine the effect of weight loss on a wide range of biomarkers associated with risk of breast cancer recurrence in overweight and obese breast cancer survivors. We hypothesized that weight loss would result in a statistically significant improvement in biomarkers associated with risk of breast cancer recurrence.

Conditions

Interventions

OTHER

Calorie restricted diet plus exercise

Daily meals plus exercise providing 1000 kcal restriction per day for 12 weeks.

OTHER

Weight management classes

Weekly 1-hour weight management classes for 12 weeks.

Sponsors & Collaborators

  • National Cancer Institute (NCI)

    collaborator NIH

  • USDA Grand Forks Human Nutrition Research Center

    lead FED

Principal Investigators

  • Susan Raatz, PhD, MPH, RD · USDA Grand Forks Human Nutrition Research Center

  • Mindy S Kurzer, PhD, MPH, RD · University of Minnesota

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
44 Years
Max Age
75 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2009-01-31
Primary Completion
2010-01-31
Completion
2010-08-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02940470 on ClinicalTrials.gov